[1]
|
Epstein, M.A., Achong, B.G. and Barr, Y.M. (1964) Virus Particles in Cultured Lymphoblasts from Burkitt’s Lymphoma. Lancet, 293, 702-703. https://doi.org/10.1016/S0140-6736(64)91524-7
|
[2]
|
Nowalk, A. and Green, M. (2016) Epstein-Barr Virus. Microbiology Spectrum, 4.
https://doi.org/10.1128/microbiolspec.DMIH2-0011-2015
|
[3]
|
Khan, G. and Hashim, M.J. (2014) Global Burden of Deaths from Epstein-Barr Virus Attributable Malignancies 1990-2010. Infect Agent Cancer, 9, Article No. 38. https://doi.org/10.1186/1750-9378-9-38
|
[4]
|
尹静. 儿童传染性单核细胞增多症的临床治疗方法研究进展[J]. 中国处方药, 2019,17(6): 32-34.
|
[5]
|
诸福棠实用儿科学(第8版) [J]. 中国临床医生杂志, 2015, 43(7): 47.
|
[6]
|
欧阳文献, 张慧, 刘静, 谭艳芳, 于四景, 唐莲, 等. 儿童传染性单核细胞增多症临床特征及治疗的单中心研究[J]. 中华实验和临床病毒学杂志, 2018, 32(1): 12-16.
|
[7]
|
胡岩岩, 潘家华, 周浩泉. 儿童传染性单核细胞增多症临床及实验室检查特点分析[J]. 中华全科医学, 2021, 19(9): 1510-1513.
|
[8]
|
Jiang, L., Gu, Z.H., Yan, Z.X., Zhao, X., Xie, Y.Y., Zhang, Z.G., et al. (2015) Exome Sequencing Identifies Somatic Mutations of DDX3X in Natural Killer/T-Cell Lymphoma. Nature Genetics, 47, 1061-1066.
https://doi.org/10.1038/ng.3358
|
[9]
|
Arai, A. (2018) Chronic Active Epstein-Barr Virus Infection: A Bi-Faceted Disease with Inflammatory and Neoplastic Elements. Immunological Medicine, 41, 162-169. https://doi.org/10.1080/25785826.2018.1556030
|
[10]
|
Murata, T., Okuno, Y., Sato, Y., Watanabe, T. and Kimura, H. (2020) Oncogenesis of CAEBV Revealed: Intragenic Deletions in the Viral Genome and Leaky Expression of Lytic Genes. Reviews in Medical Virology, 30, Article No. e2095. https://doi.org/10.1002/rmv.2095
|
[11]
|
Arai, A. (2019) Advances in the Study of Chronic Active Epstein-Barr Virus Infection: Clinical Features Under the 2016 WHO Classification and Mechanisms of Development. Frontiers in Pediatrics, 7, Article No. 14.
https://doi.org/10.3389/fped.2019.00014
|
[12]
|
Jones, J.F., Shurin, S., Abramowsky, C., Tubbs, R.R., Sciotto, C.G., Wahl, R., et al. (1988) T-Cell Lymphomas Containing Epstein-Barr Viral DNA in Patients with Chronic Epstein-Barr Virus Infections. New England Journal of Medicine, 318, 733-741. https://doi.org/10.1056/NEJM198803243181203
|
[13]
|
Straus, S.E. (1988) The Chronic Mononucleosis Syndrome. The Journal of Infectious Diseases, 157, 405-412.
https://doi.org/10.1093/infdis/157.3.405
|
[14]
|
Okano, M., Kawa, K., Kimura, H., Yachie, A., Wakiguchi, H., Maeda, A., et al. (2005) Proposed Guidelines for Diagnosing Chronic Active Epstein-Barr Virus Infection. American Journal of Hematology, 80, 64-69.
https://doi.org/10.1002/ajh.20398
|
[15]
|
Swerdlow, S.H., Campo, E., Pileri, S.A., Harris, N.L., Stein, H., Siebert, R., et al. (2016) The 2016 Revision of the World Health Organization Classification of Lymphoid Neoplasms. Blood, 127, 2375-2390.
https://doi.org/10.1182/blood-2016-01-643569
|
[16]
|
中华医学会儿科学分会感染学组, 全国儿童EB病毒感染协作组. 儿童主要非肿瘤性EB病毒感染相关疾病的诊断和治疗原则建议[J]. 中华儿科杂志, 2016, 54(8): 563-568.
|
[17]
|
Arai, A. (2021) The Road to Treating Chronic Active Epstein-Barr Viral Infection. Rinsho Ketsueki, 62, 835-845.
|
[18]
|
Janka, G.E. (2007) Familial and Acquired Hemophagocytic Lymphohistiocytosis. European Journal of Pediatrics, 166, 95-109. https://doi.org/10.1007/s00431-006-0258-1
|
[19]
|
Janka, G.E. and Lehmberg, K. (2014) Hemophagocytic Syndromes—An Update. Blood Reviews, 28, 135-142.
https://doi.org/10.1016/j.blre.2014.03.002
|
[20]
|
Bergsten, E., Horne, A., Arico, M., Astigarraga, I., Egeler, R.M., Filipovich, A.H., et al. (2017) Confirmed Efficacy of Etoposide and Dexamethasone in HLH Treatment: Long-Term Results of the Cooperative HLH-2004 Study. Blood, 130, 2728-2738. https://doi.org/10.1182/blood-2017-06-788349
|
[21]
|
Hayden, A., Park, S., Giustini, D., Lee, A.Y. and Chen, L.Y. (2016) Hemophagocytic Syndromes (HPSs) Including Hemophagocytic Lymphohistiocytosis (HLH) in Adults: A Systematic Scoping Review. Blood Reviews, 30, 411-420.
https://doi.org/10.1016/j.blre.2016.05.001
|
[22]
|
Nilsson, K., Klein, G., Henle, W. and Henle, G. (1971) The Establishment of Lymphoblastoid Lines from Adult and Fetal Human Lymphoid Tissue and Its Dependence on EBV. International Journal of Cancer, 8, 443-450.
https://doi.org/10.1002/ijc.2910080312
|
[23]
|
吴克复, 郑国光, 马小彤, 宋玉华. EB病毒感染的多样性及其意义[J]. 中国肿瘤临床, 2021, 48(7): 330-335.
|
[24]
|
Amon, W. and Farrell, P.J. (2005) Reactivation of Epstein-Barr Virus from Latency. Reviews in Medical Virology, 15, 149-156. https://doi.org/10.1002/rmv.456
|
[25]
|
Murata, T. (2014) Regulation of Epstein-Barr Virus Reactivation from Latency. Microbiology and Immunology, 58, 307-317. https://doi.org/10.1111/1348-0421.12155
|
[26]
|
Taylor, G.S., Long, H.M., Brooks, J.M., Rickinson, A.B. and Hislop, A.D. (2015) The Immunology of Epstein-Barr Virus-induced Disease. Annual Review of Immunology, 33, 787-821.
https://doi.org/10.1146/annurev-immunol-032414-112326
|
[27]
|
Vockerodt, M., Yap, L.F., Shannon-Lowe, C., Curley, H., Wei, W., Vrzalikova, K., et al. (2015) the Epstein-Barr Virus and the Pathogenesis of Lymphoma. The Journal of Pathology, 235, 312-322. https://doi.org/10.1002/path.4459
|
[28]
|
王思力, 方志鸿, 黄耘, 林志娟, 苏蕊. 肿瘤坏死因子α在不同类型淋巴瘤患者中的表达及其临床预后意义[J]. 中华血液学杂志, 2014, 35(12): 1107-1110.
|
[29]
|
Roemer, M.G., Advani, R.H., Ligon, A.H., Natkunam, Y., Redd, R.A., Homer, H., et al. (2016) PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome. Journal of Clinical Oncology, 34, 2690-2697. https://doi.org/10.1200/JCO.2016.66.4482
|
[30]
|
Weiss, L.M., Strickler, J.G., Warnke, R.A., Purtilo, D.T. and Sklar, J. (1987) Epstein-Barr Viral DNA in Tissues of Hodgkin’s Disease. The American Journal of Pathology, 129, 86-91.
|
[31]
|
Wu, T.C., Mann, R.B., Charache, P., Hayward, S.D., Staal, S. and Lambe, B.C., et al. (1990) Detection of EBV Gene Expression in Reed-Sternberg Cells of Hodgkin’s Disease. International Journal of Cancer, 46, 801-804.
https://doi.org/10.1002/ijc.2910460509
|
[32]
|
Shanbhag, S. and Ambinder, R.F. (2018) Hodgkin Lymphoma: A Review and Update on Recent Progress. CA: A Cancer Journal for Clinicians, 68, 116-132. https://doi.org/10.3322/caac.21438
|
[33]
|
Wang, H.W., Balakrishna, J.P., Pittaluga, S., Purtilo, D.T. and Sklar, J. (2019) Diagnosis of Hodgkin Lymphoma in the Modern Era. British Journal of Haematology, 184, 45-59. https://doi.org/10.1111/bjh.15614
|
[34]
|
(1997) A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma. The Non-Hodgkin’s Lymphoma Classification Project. Blood, 89, 3909-3918.
https://doi.org/10.1182/blood.V89.11.3909
|
[35]
|
Tracy, S.I., Habermann, T.M., Feldman, A.L., Maurer, M.J., Dogan, A., Perepu, U.S., et al. (2018) Outcomes among North American Patients with Diffuse Large B-Cell Lymphoma Are Independent of Tumor Epstein-Barr Virus Positivity or Immunosuppression. Haematologica, 103, 297-303. https://doi.org/10.3324/haematol.2017.176511
|
[36]
|
Park, S., Lee, J., Ko, Y.H., Han, A., Jun, H.J., Lee, S.C., et al. (2007) The Impact of Epstein-Barr Virus Status on Clinical Outcome in Diffuse Large B-Cell Lymphoma. Blood, 110, 972-978.
https://doi.org/10.1182/blood-2007-01-067769
|
[37]
|
Witte, H.M., Merz, H., Biersack, H., Bernard, V., Riecke, A., Gebauer, J., et al. (2020) Impact of Treatment Variability and Clinicopathological Characteristics on Survival in Patients with Epstein-Barr-Virus Positive Diffuse Large B Cell Lymphoma. British Journal of Haematology, 189, 257-268. https://doi.org/10.1111/bjh.16342
|
[38]
|
Oyama, T., Ichimura, K., Suzuki, R., Suzumiya, J., Ohshima, K., Yatabe, Y., et al. (2003) Senile EBV+ B-Cell Lymphoproliferative Disorders: A Clinicopathologic Study of 22 Patients. British Journal of Haematology, 27, 16-26.
https://doi.org/10.1097/00000478-200301000-00003
|
[39]
|
Strnad, J. and Burke, J.R. (2007) IκB Kinase Inhibitors for Treating Autoimmune and Inflammatory Disorders: Potential and Challenges. Trends in Pharmacological Sciences, 28, 142-148. https://doi.org/10.1016/j.tips.2007.01.005
|
[40]
|
Dunleavy, K., Little, R.F. and Wilson, W.H. (2016) Update on Burkitt Lymphoma. Hematology/Oncology Clinics of North America, 30, 1333-1343. https://doi.org/10.1016/j.hoc.2016.07.009
|
[41]
|
Schmitz, R., Young, R.M., Ceribelli, M., Jhavar, S., Xiao, W., Zhang, M., et al. (2012) Burkitt Lymphoma Pathogenesis and Therapeutic Targets from Structural and Functional Genomics. Nature, 490, 116-120.
https://doi.org/10.1038/nature11378
|